Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients. ACT is already available in the clinic for some diseases — CAR… Read More »
Cancer treatments can work, but the same factors that help them eradicate tumors may also accelerate aging processes in the body — especially the brain. New research explores. Breast cancer treatments leave their mark on the brain years after completion, a new study suggests. Previously on Medical News Today, we covered a study explaining that… Read More »
Metastatic breast cancer (MBC) can make patients feel isolated, and that’s the feeling Eisai is working to combat with its latest awareness campaign. The Japanese drugmaker has rolled out an initiative dubbed “FurtherMore,” which highlights the real-life stories of advanced breast cancer patients and “celebrates what can be achieved when they get the support they… Read More »
((This NOV 19 story corrects to show Merck is Palantir’s exclusive partner within the JV, not for all of Palantir’s healthcare activities, paragraph 11)) FILE PHOTO: Merck CEO Stefan Oschmann delivers a speech during the celebrations of the 350th anniversary of German pharmaceuticals company Merck at the Merck headquarters in Darmstadt, Germany, May 3 ,2018.… Read More »